MRI in Staging Ovarian Cancer Using MRI Contrast Agent
NCT00463996 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2007-04-20
Summary
Can MRI be used to stage ovarian cancer?
Conditions
Sponsors & Collaborators
-
University of Aarhus
lead OTHER
Principal Investigators
-
Liselotte Ibsen, doc · Aarhus University Hospital, BDA, Skejby
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-04-30
- Completion
- 2008-04-30
More Related Trials
-
New Biomarkers Evaluating Ovarian Cancer
NCT01466049 ·Status: COMPLETED
-
Early Assessment of Ovarian Cancer Aggressiveness by Metabolic Imaging
NCT05866679 ·Status: SUSPENDED ·Phase: PHASE1
-
Contrast-Enhanced Ultrasonography in Diagnosing Early-Stage Ovarian Cancer in Patients With an Adnexal Mass Undergoing Surgery to Remove the Ovary
NCT00626873 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Gated PET/CT in the Diagnosis of Advanced Ovarian Cancer
NCT02258165 ·Status: COMPLETED
-
Factors Affecting the Prognosis of Early Ovarian Cancer
NCT04414683 ·Status: UNKNOWN
-
Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Ovarian Cancer
NCT05410015 ·Status: RECRUITING
-
Ovarian Cancer Radiomics Approach in CT Led Evaluation
NCT06817174 ·Status: RECRUITING
-
The IGF Axis Involvement in Immune Tumor Microenvironment in Ovarian Cancer and Its Clinical Significance
NCT03846856 ·Status: UNKNOWN
-
Evaluation of Chemotherapy Influence on Clinical and Biological Markers of Ovarian Reserve
NCT00712452 ·Status: TERMINATED ·Phase: NA
-
Oxford Ovarian Cancer Predict Chemotherapy Response 01
NCT01770535 ·Status: UNKNOWN
-
Lymphadenectomy in Early Ovarian Cancer
NCT04710797 ·Status: RECRUITING ·Phase: NA
-
Venous Thromboembolic Complications in Ovarian Cancer
NCT02480790 ·Status: UNKNOWN
-
Ovarian Reserve After Cancer: Longitudinal Effects
NCT02467231 ·Status: ACTIVE_NOT_RECRUITING
-
The Analyses of Treatment Efficacy and Cost-effectiveness in Early-staged Ovarian Cancer Patients
NCT03019315 ·Status: UNKNOWN
-
Use of New MolEcular MarkErs for a persoNalized Therapy in Ovarian Cancer-MEMENTO
NCT06917469 ·Status: COMPLETED
-
Sentinel Node Detection in Clinical Early Stage Ovarian Cancer
NCT01734746 ·Status: COMPLETED ·Phase: NA
-
The Efficacy and Safety of FRD001 in Ultrasound Contrast Imaging for Malignant Ovarian Masses in Women
NCT06556342 ·Status: RECRUITING ·Phase: NA
-
Tumor Microenvironment in Ovarian Cancer
NCT06272240 ·Status: RECRUITING
-
A Trial of Fast Access to Transvaginal Ultrasound Through General Practice for Earlier Diagnosis of Ovarian Cancer
NCT03069872 ·Status: COMPLETED ·Phase: NA
-
Epithelial Ovarian Cancer- Staging and Response to Chemotherapy Evaluated by PET/CT
NCT01276574 ·Status: ACTIVE_NOT_RECRUITING
-
Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for Cancer
NCT00402935 ·Status: WITHDRAWN
-
Improving Quality of Care for Patients With Recurrent Ovarian Cancer
NCT02809339 ·Status: UNKNOWN
-
Liquid Biopsies for Improving the Pre-operative Diagnosis of Ovarian Cancer
NCT04971421 ·Status: UNKNOWN
-
Assessment of Ovarian Reserve in Female Cancer Survivors
NCT01062542 ·Status: COMPLETED
-
Spectroscopy in Ovarian Cancer
NCT04817449 ·Status: COMPLETED